Mar 15, 2022
Data Demonstrates Clinically Meaningful and Statistically Significant Results, Improving Glycemic Control by Reducing A1c 0.4% Versus the Control Group Receiving Standard of Care SAN FRANCISCO --(BUSINESS WIRE)--Mar. 15, 2022-- Better Therapeutics, Inc. (“Better Therapeutics”, NASDAQ: BTTX), a
Displaying 1 - 10 of 41